Notice Information
Notice Title
NP40925 Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines
Notice Description
This Framework Agreement is for the supply of Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines to health boards across NHS Scotland. The Goods have been split into twenty (20) categories, each of which is identified as a "Lot". Full details of each Lot is contained in section II.2 of this notice.
Lot Information
Lot 1 - Baclofen Intrathecal Injections
Supply of Baclofen Intrathecal Injections to NHS Scotland in a range of presentations. The Authority has awarded all presentations within this lot to a single Framework Participant.
Renewal: This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire.
Lot 2 - Oxycodone InjectionsThe Supply of Oxycodone Injections to NHS Scotland in a range of presentations. The Authority has awarded all presentations within this lot to a single Framework Participant.
Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Lot 3 - Levobupivacaine (As Hydrochloride) Sterile Wrapped Ampoules For InjectionThe Supply of Levobupivacaine (As Hydrochloride) Sterile Wrapped Ampoules For Injection to NHS Scotland in a range of presentations. The Authority has awarded all presentations within this lot to a single Framework Participant.
Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Lot 4 - Oxycodone Hydrochloride Prolonged Release TabletsThe Supply of Oxycodone Hydrochloride Prolonged Release Tablets to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis.
Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Lot 5 - Buprenorphine PatchesThe supply of Buprenorphine Patches to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis.
Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Lot 6 - Fentanyl Tablets (Sublingual)The Supply of Fentanyl Tablets (Sublingual) to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis.
Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Lot 7 - Fentanyl Sf Tablet (Buccal)Supply of Fentanyl Sf Tablets(Buccal) to NHS Scotland in a range of presentations. The Authority has not awarded this Lot.
Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Lot 8 - Fentanyl Transdermal PatchSupply of Fentanyl Transdermal Patch to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis.
Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Lot 9 - HydromorphoneSupply of Hydromorphone Capsules and Injection to NHS Scotland in a range of presentations. The Authority has awarded each product line within this lot to a single Framework Participant.
Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Lot 10 - Lidocaine Chlorhexidine GelSupply of Lidocaine Chlorhexidine Gel to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis.
Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Lot 11 - Morphine Sulfate Modified-Release capsule (12Hr)Supply of Morphine Sulfate Modified-Release capsule (12hr) to NHS Scotland in a range of presentations. The Authority has awarded all presentations within this lot to a single Framework Participant.
Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Lot 12 - Morphine Sulfate Modified-Release capsule (24Hr)The Supply of Morphine Sulfate Modified-Release capsule (24Hr) to NHS Scotland in a range of presentations. The Authority has awarded all presentations within this lot to a single Framework Participant.
Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Lot 13 - Morphine Sulfate Modified-Release TabletThe Supply of Morphine Sulfate Modified-Release Tablet to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis.
Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Lot 14 - Oxycodone Hydrochloride CapsulesThe Supply of Oxycodone Hydrochloride Capsules to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis.
Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Lot 15 - Propofol InjectionThe Supply of Propofol Injection to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis.
Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Lot 16 - Tramadol Hydrochloride Modified Release TabletsThe Supply of Tramadol Hydrochloride Modified Release Tablets to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis.
Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Lot 17 - Oxycodone Oral SolutionThe Supply of Oxycodone Oral Solution to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis.
Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Lot 18 - Levobupivacaine (As Hydrochloride) Solution For InfusionThe Supply of Levobupivacaine (As Hydrochloride) Solution For Infusion to NHS Scotland in a range of presentations. The Authority has awarded each product line as a multi-supplier unranked framework agreement on a line by line basis.
Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Lot 19 - Supply to NHSS Pharmaceuticals "Specials" ServiceThe supply of a range of Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines to the NHSS Pharmaceuticals "Specials" Service. The Authority has awarded each product line within this Lot to a single Framework Participant.
Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Lot 20 - Levobupivacaine Solution for injection ampoules (unwrapped)Supply of Levobupivacaine solution for injection ampoules (unwrapped) all other Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines in a range of presentations. The Authority has awarded each product line within this Lot to a single Framework Participant.
Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Lot 21 - All other Analgesics and Anaesthetic Generic MedicinesSupply of all other Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines in a range of presentations. The Authority has awarded each product line within this Lot to a single Framework Participant.
Renewal: This framework includes the option(s) to extend for up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Notice Details
Publication & Lifecycle
- Open Contracting ID
- ocds-r6ebe6-0000796255
- Publication Source
- Public Contracts Scotland
- Latest Notice
- https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=JAN546536
- Current Stage
- Award
- All Stages
- Tender, Award
Procurement Classification
- Notice Type
- OJEU - F3 - Contract Award Notice
- Procurement Type
- Framework
- Procurement Category
- Goods
- Procurement Method
- Open
- Procurement Method Details
- Open procedure
- Tender Suitability
- Not specified
- Awardee Scale
- SME
Common Procurement Vocabulary (CPV)
- CPV Divisions
33 - Medical equipments, pharmaceuticals and personal care products
-
- CPV Codes
33600000 - Pharmaceutical products
Notice Value(s)
- Tender Value
- £52,999,636 £10M-£100M
- Lots Value
- £52,999,636 £10M-£100M
- Awards Value
- Not specified
- Contracts Value
- £22,471,323 £10M-£100M
Notice Dates
- Publication Date
- 6 Jan 20267 months ago
- Submission Deadline
- 8 Sep 2025Expired
- Future Notice Date
- Not specified
- Award Date
- 12 Dec 20258 months ago
- Contract Period
- Not specified - Not specified
- Recurrence
- Not specified
Notice Status
- Tender Status
- Complete
- Lots Status
- Complete
- Awards Status
- Unsuccessful
- Contracts Status
- Active
Buyer & Supplier
Contracting Authority (Buyer)
- Main Buyer
- The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")
- Contact Name
- Available with D3 Tenders Premium →
- Contact Email
- Available with D3 Tenders Premium →
- Contact Phone
- Available with D3 Tenders Premium →
Buyer Location
- Locality
- EDINBURGH
- Postcode
- EH12 9EB
- Postcode Area
- Edinburgh
- Country
- Scotland
-
- Major Region (ITL 1)
- TLM Scotland
- Basic Region (ITL 2)
- TLM1 East Central Scotland
- Small Region (ITL 3)
- TLM13 City of Edinburgh
- Delivery Location
- TLM Scotland
-
- Local Authority
- City of Edinburgh
- Electoral Ward
- Drum Brae/Gyle
- Westminster Constituency
- Edinburgh South West
Further Information
Notice Documents
-
https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=AUG536383
NP40925 Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines - This Framework Agreement is for the supply of Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines to health boards across NHS Scotland. The Goods have been split into twenty (20) categories, each of which is identified as a "Lot". Full details of each Lot is contained in section II.2 of this notice. -
https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=JAN546536
NP40925 Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines - This Framework Agreement is for the supply of Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines to health boards across NHS Scotland. The Goods have been split into twenty (20) categories, each of which is identified as a "Lot". Full details of each Lot is contained in section II.2 of this notice.
Open Contracting Data Standard (OCDS)
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.